Patents Assigned to Effcon Laboratories, Inc.
  • Patent number: 11504358
    Abstract: A once-a-day controlled release oral dosage form of methazolamide is provided. The dosage form comprises a therapeutically effective amount of methazolamide and a high molecular weight binder. The dosage is configured for once-daily administration to a subject in need thereof, and releases methazolamide over a period of about twenty-four hours.
    Type: Grant
    Filed: August 4, 2021
    Date of Patent: November 22, 2022
    Assignee: Effcon Laboratories, Inc.
    Inventor: Nabil Rizk
  • Patent number: 11103485
    Abstract: A once-a-day controlled release oral dosage form of methazolamide is provided. The dosage form comprises a therapeutically effective amount of methazolamide and a high molecular weight binder. The dosage is configured for once-daily administration to a subject in need thereof, and releases methazolamide over a period of about twenty-four hours.
    Type: Grant
    Filed: November 14, 2019
    Date of Patent: August 31, 2021
    Assignee: Effcon Laboratories, Inc.
    Inventor: Nabil Rizk
  • Patent number: 10493063
    Abstract: A once-a-day controlled release oral dosage form of methazolamide is provided. The dosage form comprises a therapeutically effective amount of methazolamide and a high molecular weight binder. The dosage is configured for once-daily administration to a subject in need thereof, and releases methazolamide over a period of about twenty-four hours.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: December 3, 2019
    Assignee: Effcon Laboratories, Inc.
    Inventor: Nabil Rizk
  • Patent number: 9980946
    Abstract: A once-a-day controlled release oral dosage form of methazolamide is provided. The dosage form comprises a therapeutically effective amount of methazolamide and a high molecular weight binder. The dosage is configured for once-daily administration to a subject in need thereof, and releases methazolamide over a period of about twenty-four hours.
    Type: Grant
    Filed: June 13, 2017
    Date of Patent: May 29, 2018
    Assignee: EFFCON LABORATORIES, INC.
    Inventor: Nabil Rizk
  • Patent number: 7902256
    Abstract: The present invention provides a pediculicidal and ovicidal composition with an extraordinarily lethal effectiveness that can also be used to remove parasites, such as lice. The pediculicidal and ovicidal composition contains a purified terpene agent such as citronellal, citronellol, citronellyl or a mixture thereof, a short chain alcohol, and a non-aqueous co-solvent and/or surfactant component. The composition more preferably utilizes citronellyl acetate as the active agent. The compositions can be administered topically to humans, animals or any infested areas.
    Type: Grant
    Filed: July 10, 2007
    Date of Patent: March 8, 2011
    Assignee: Effcon Laboratories, Inc.
    Inventor: Jeffrey H. Ping
  • Patent number: 6350724
    Abstract: The present invention provides a composition, and a method of use thereof, that is pesticide-free and yet is capable of cleansing an individual of a pest infestation. The composition of the present invention consists essentially of an acid, an alcohol, an aqueous detergent and water. The composition is used in the removal of pests and their ova from infested individuals. Preferably, the composition of the present invention takes the form of a shampoo and is used to cleanse individuals of lice infestations. In use, the composition is applied to hair and allowed to remain in contact with the hair and scalp for a period of time, called the residence time. After the residence time, the composition is rinsed from the hair. Then, the hair is combed with a suitable nit comb. These treatment steps may be repeated as necessary and appropriate to effectuate the removal of the pest infestation.
    Type: Grant
    Filed: August 13, 1999
    Date of Patent: February 26, 2002
    Assignee: Effcon Laboratories, Inc.
    Inventors: Jeffrey S. Kiel, Jeffrey H. Ping